GSK's number of employees by region 2011-2023
In 2023, the number of GSK (GlaxoSmithKline) employees in Europe totaled about 32,700 thousand. The number of employees in Europe stood at a record-high of almost 44 thousand in 2015, but dropped since then back to some 31,800.
GlaxoSmithKline’s pharmaceuticals
GlaxoSmithKIine is a global pharmaceutical manufacturer and developer that creates medicines, vaccinations and consumer health products. In 2022, GlaxoSmithKline was among the global top ten pharmaceutical companies based on pharmaceutical sales. GlaxoSmithKline has many kinds of pharmaceuticals available and they excel in certain sectors, such as respiratory pharmaceuticals. As an example, Advair, a respiratory pharmaceutical product marketed by GlaxoSmithKline, is among the top respiratory medications based on revenue.
GlasxoSmithKline’s global revenue
From 2006 to 2021, GlaxoSmithKline’s revenues generally saw some ups and downs with growth in more recent years. GlaxoSmithKline has numerous sectors and divisions within the company. Within those sectors, pharmaceuticals and vaccines have provided a significant proportion of the company’s yearly revenues. GlaxoSmithKline’s revenue is regionally variable. The United States accounts for the largest proportion of GlaxoSmithKline’s revenue.
GlaxoSmithKline’s pharmaceuticals
GlaxoSmithKIine is a global pharmaceutical manufacturer and developer that creates medicines, vaccinations and consumer health products. In 2022, GlaxoSmithKline was among the global top ten pharmaceutical companies based on pharmaceutical sales. GlaxoSmithKline has many kinds of pharmaceuticals available and they excel in certain sectors, such as respiratory pharmaceuticals. As an example, Advair, a respiratory pharmaceutical product marketed by GlaxoSmithKline, is among the top respiratory medications based on revenue.
GlasxoSmithKline’s global revenue
From 2006 to 2021, GlaxoSmithKline’s revenues generally saw some ups and downs with growth in more recent years. GlaxoSmithKline has numerous sectors and divisions within the company. Within those sectors, pharmaceuticals and vaccines have provided a significant proportion of the company’s yearly revenues. GlaxoSmithKline’s revenue is regionally variable. The United States accounts for the largest proportion of GlaxoSmithKline’s revenue.
